Fabiana Covolo de Souza Santana

Fabiana Covolo de Souza Santana

Auto-generated profile, based on publicly available information

Fabiana Covolo de Souza Santana

Immunology Technical Team, Lauro de Souza Lima Institute, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2016 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
LRLeandro D. Ramire
Leandro D. Ramire
EMElaine V. C. Marcos
Elaine V. C. Marcos
DGDeise A. S. Godoy
Deise A. S. Godoy
FSFabiana C. de Souza‐Santana
Fabiana C. de Souza‐Santana

12 August 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LJLuciana Ribeiro Jarduli
Luciana Ribeiro Jarduli
HAHugo Vicentin Alves
Hugo Vicentin Alves
FSFabiana Covolo de Souza-Santana
Fabiana Covolo de Souza-Santana
EMElaine V Camarinha Marcos
Elaine V Camarinha Marcos
APAna Carla Pereira
Ana Carla Pereira
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
Background: The objective of this study was to investigate the association between KIR genes and the immunopathogenesis of leprosy.Methods: The types of KIR and HLA genes were evaluated by PCR-SSOP-Luminex in 408 patients with leprosy and 413 healthy individuals. Statistical analysis was performed using the Chi-square or Fisher’s exact test and stepwise multivariate analysis.Results: There was a higher frequency of activating KIR genes (KIR2DS1,2DS2and3DS1) together with their HLA ligands in the tuberculoid (TT) group as compared to the lepromatous leprosy (LL) group.KIR2DL2/2DL2-C1was more frequent in the patient, TT and LL groups than in the control group. Borderline patients presented a higher frequency of inhibitory pairs when compared to the control group, and a higher frequency of activating pairs as compared to the LL group. Multivariate analysis confirmed the associations and demonstrated that being a female is a protective factor against the development of the diseaseper seand the more severe clinical form.Conclusions: This study showed that activating and inhibitory KIR genes may influence the development of leprosy – in particular, activating genes may protect against the more aggressive form of the disease – thereby demonstrating the role of NK cells in the immunopathology of the disease.

1 March 2014 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
LSLuana de Cassia Salvadori
Luana de Cassia Salvadori
FSFabiana Covolo de Souza Santana
Fabiana Covolo de Souza Santana
EMElaine Valim Camarinha Marcos
Elaine Valim Camarinha Marcos
HLA allele identification is used in bone marrow transplant programs as HLA compatibility between the donor and recipient may prevent graft rejection. This study aimed to estimate the frequency of alleles and haplotypes of the HLA system in the region of Bauru and compare these with the frequencies found in other regions of the country. HLA-A*, HLA-B*, and HLA-DRB1* allele frequencies and haplotypes were analyzed in a sample of 3542 volunteer donors at the National Registry of Voluntary Bone Marrow Donors (REDOME) in Bauru. HLA low resolution typing was performed using reverse line blot with the Dynal Reli(tm) SSO-HLA Typing Kit and automated Dynal AutoReli(tm)48 device (Invitrogen, USA). Twenty, 36, and 13 HLA-A*, HLA-B*, and HLA-DRB1* allele groups, respectively, were identified. The most common alleles for each locus were HLA-A*02, HLA-B*35, and HLA-DRB1*07. The most frequent haplotype was A*01-B*08-DRB1*03. Allele and haplotype frequencies were compared to other regions in Brazil and the similarities and differences among populations are shown. The knowledge of the immunogenic profile of a population contributes to the comprehension of the historical and anthropological aspects of different regions. Moreover, this helps to find suitable donors quickly, thereby shortening waiting lists for transplants and thus increasing survival rates among recipients.

21 January 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
FSFabiana Covolo de Souza-Santana
Fabiana Covolo de Souza-Santana
EMElaine V Camarinha Marcos
Elaine V Camarinha Marcos
MNMaria Esther Salles Nogueira
Maria Esther Salles Nogueira
SUSomei Ura
Somei Ura
JTJane Tomimori
Jane Tomimori
Evidence suggests that human leukocyte antigen (HLA) alleles influence the host immune response against Mycobacterium leprae. However, the association between HLA alleles and borderline (B) leprosy has not been studied. The aim of this study was to determine whether HLA class I and II molecules are associated with susceptibility or resistance to B leprosy including borderline-tuberculoid (BT), borderline-borderline (BB), and borderline-lepromatous (BL). DNA was obtained by the salting-out technique from the blood samples of 202 patients with B leprosy and 478 control subjects. HLA class I (A*, B*, and C* loci) and class II (DRB1* and DQB1* loci) genotypes were determined by polymerase chain reaction amplification and reverse hybridization with sequence-specific oligonucleotide probes and sequence-specific primers. The case-controlled analysis results showed a significant association between B leprosy and HLA-C*05 (5.94% vs. 14.02%; p = 0.002, OR = 0.38, 95% CI = 0.20–0.73, pc = 0.032) and HLA-DRB1*07 (16.34% vs. 26.77%; p = 0.003, OR = 0.53, 95% CI = 0.3–0.8, pc = 0.039). A protective association was observed between BL leprosy and HLA-DQB1*02 (18.18% vs. 39.53%; p = 0.005, OR = 0.34, 95% CI = 0.15–0.75, pc = 0.025). In reactional patients, a significant association was observed between HLA-B*15 (28.72% vs. 12.76%; p = 0.011, OR = 2.75, 95% CI = 1.30–5.85, pc = 0.352) and predisposition to reversal reaction. Haplotype analysis showed that A*02-B*07-C*07-DRB1*15-DQB1*06 (2.97% vs. 1.04%; p = 0.015) and A*02-B*40-C*03-DRB1*13-DQB1*06 (1.73% vs. 0.10%; p = 0.0011) were associated with susceptibility to the B form. The presence of the HLA-DRB1*02 or HLA-DRB1*03/HLA-DQB1*01 haplotypes in B patients (22.05% vs. 33.0%; p = 0.005) suggested the involvement of these haplotypes in this clinical form of the disease. The results indicate the involvement of HLA class I and class II molecules in B leprosy and reversal reactions; it also suggest a role for HLA in polarization of the disease in this group of patients.

1 April 2007 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
FSFabiana Covolo de Souza
Fabiana Covolo de Souza
EMElaine Valim Camarinha Marcos
Elaine Valim Camarinha Marcos
SUSomei Ura
Somei Ura
POPaula Araújo Opromolla
Paula Araújo Opromolla
MNMaria Esther Salles Nogueira
Maria Esther Salles Nogueira
Neste estudo, propomos comparar o teste cutâneo de Mitsuda e os alelos HLA-DR2/HLA-DR3 e HLA-DQ1 relacionados com as formas clínicas da hanseníase em 176 pacientes (50 TT, 50 LL e 76 B). Os resultados obtidos não revelaram associação entre reação de Mitsuda e os alelos HLA nas formas clínicas isoladas; no entanto, quando analisados de acordo com a resposta ao teste de Mitsuda, associação significativa foi encontrada entre os pacientes Mitsuda negativos e HLA-DQ1 (p=0,002). Não foi observada associação entre reação de Mitsuda positiva e alelos HLA-DR2/DR3. Concluímos que existe importante participação do alelo HLA-DQ1 na ausência de resposta ao teste de Mitsuda. Sugerimos estudos mais específicos para este alelo.

19 August 2025 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
FSFabiana Covolo de Souza Santana
Fabiana Covolo de Souza Santana
DFDébora Regina Fernandes
Débora Regina Fernandes
LFLuciana Raquel Vicenzi Fachin
Luciana Raquel Vicenzi Fachin
CSCleverson Teixeira Soares
Cleverson Teixeira Soares
ABAndrea Faria Fernandes Belone
Andrea Faria Fernandes Belone
VSVânia Nieto Brito de Souza
Vânia Nieto Brito de Souza
Background: The immunological context of leprosy is influenced by mechanisms closely associated with the human leukocyte antigen (HLA). HLA-G, a non-classical class I (Ib) molecule, plays a key role in regulating immune responses and has been linked to the progression and prognosis of various diseases. Objectives: This study aimed to investigate HLA-G expression both in situ and in its soluble form in patients with different forms of leprosy, such as tuberculoid (TT), borderline tuberculoid (BT), borderline lepromatous (BL), and lepromatous leprosy (LL) and leprosy reactions, such as reversal reaction (RR) and erythema nodosum leprosum (ENL). Methods: Biopsy samples from 71 patients and eight healthy controls were used for HLA-G immunohistochemistry. Serum samples from 43 patients and five controls were used to detect soluble HLA-G by ELISA. Results: In situ HLA-G expression was observed in 78.6% of TT, 58.8% of BT, 60.0% of BB, 31.2% of BL, and 21.4% of LL patients. Among patients with leprosy reactions, 72.7% of RR and 33.3% of ENL showed HLA-G expression. TT patients exhibited higher expression than healthy controls (p=0.007) and LL patients (p=0.043). The levels of soluble HLA-G were similar in all clinical forms and leprosy reactions. Limitations: This study was limited by a small sample size, particularly in the ENL group of patients. This may have influenced the results. Furthermore, the ability to investigate soluble HLA-G (sHLA-G) was limited by the number of patients available for this analysis. Additionally, the study’s cross-sectional design did not allow for assessing changes in HLA-G expression and sHLA-G levels over time. Conclusions: HLA-G expression was higher in TT leprosy patients and decreased across the clinical forms, suggesting that this molecule may modulate the course of leprosy.